Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.
Find out what a historical investment in Viking Therapeutics, Inc. would be worth today using our VKTX stock calculator.
Buying VKTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Viking Therapeutics, Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in VKTX
What is the ticker symbol of Viking Therapeutics, Inc.?
The ticker symbol for Viking Therapeutics, Inc. is VKTX.
How much is one share of VKTX?
One share of VKTX is valued at $25.06 as of 20 November 2026.
What is the market capitalisation of Viking Therapeutics, Inc. VKTX?
As of 20 November 2026 Viking Therapeutics, Inc. has a market cap of $3.30B.
What is the 52-week high for Viking Therapeutics, Inc. stock?
The Viking Therapeutics, Inc. 52-week high stock price is $43.10.
What is the 52-week low for Viking Therapeutics, Inc. stock?
The Viking Therapeutics, Inc. 52-week low stock price is $23.82.
Can I buy VKTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VKTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VKTX on Stake
Buy VKTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of VKTX from only US$10 with fractional shares